UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )


Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement

   

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

   

Definitive Proxy Statement

   

Definitive Additional Materials

   

Soliciting Material under §240.14a-12

 

Zevra Therapeutics, Inc.

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

   

Fee paid previously with preliminary materials

   

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 



 

 

 

i1.jpg

 

 

 

i2.jpg

 

 

 

i3.jpg

 

 

 

i4.jpg

 

 

 

i5.jpg

 

 

 

i6.jpg

 

 

 

i7.jpg

 

 

 

i8.jpg

 

 

 

i9.jpg

 

 

 

i10.jpg

 

 

 

i11.jpg
 

 

 

 

i12.jpg
 

 

 

 

i13.jpg

 

 

 

i14.jpg

 

 

 

i15.jpg

 

 

 

i16.jpg

 

 

 

i17.jpg

 

 

 

i18.jpg

 

 

 

i19.jpg

 

 

 

i20.jpg

 

 

 

i21.jpg
 

 

 

 

i22.jpg
 

 

 

 

i23.jpg

 

 

 

i24.jpg

 

 

 

i25.jpg

 

 

 

i26.jpg

 

 
KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more KemPharm Charts.
KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more KemPharm Charts.